Literature DB >> 1461870

The renal effects of dopamine and dobutamine in stable chronic heart failure.

J Good1, G Frost, C M Oakley, J G Cleland.   

Abstract

Although an extensive literature exists on factors controlling sodium excretion in animal experimental models of heart failure, the relevance of these to the human condition remains largely unexplored. Increased renal sympathetic stimulation is considered responsible for heightened urinary sodium retention. Stimulation of dopamine receptors is believed to cause a diuresis. Accordingly, we sought to explore the influence of dobutamine (a beta-1 receptor agonist) and dopamine in high and low doses on a frusemide-induced diuresis in patients with chronic stable heart failure. Preliminary results indicate that low doses of dobutamine and dopamine do not increase a moderate, frusemide-induced diuresis. With higher doses dobutamine, but not dopamine, increased urine volume and sodium excretion. These results suggest that direct stimulation of beta-1 receptors increases urinary sodium excretion, either by a direct effect on the kidney or by altering systemic and renal haemodynamics.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1461870

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  3 in total

1.  Aminophylline as an adjunct diuretic for neonates--a case series.

Authors:  Geraldine Yin Taeng Ng; Emma Harriet Baker; Katharine Florence Mary Farrer
Journal:  Pediatr Nephrol       Date:  2004-12-04       Impact factor: 3.714

2.  A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.

Authors:  S de Denus; J L Rouleau; D L Mann; G S Huggins; T P Cappola; S H Shah; J Keleti; Y F Zada; S Provost; A Bardhadi; M S Phillips; V Normand; I Mongrain; M-P Dubé
Journal:  Pharmacogenomics J       Date:  2016-03-01       Impact factor: 3.550

3.  Differential effects of inotropes and inodilators on renal function in acute cardiac care.

Authors:  Endre Zima; Dimitrios Farmakis; Piero Pollesello; John T Parissis
Journal:  Eur Heart J Suppl       Date:  2020-05-15       Impact factor: 1.803

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.